NCT05664035View on ClinicalTrials.gov

SPAD in Adult Patients

Not yet recruitingOBSERVATIONAL
Enrollment

99

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Specific Antibody DeficiencyPredominantly Antibody Deficiencies
Interventions
BIOLOGICAL

Diagnosis of SPAD using immunization with PPV23

Diagnosis of SPAD using immunization with PPV23

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

French Healthcare network for rare immune and hematological disorders (MARIH)

UNKNOWN

collaborator

Takeda

INDUSTRY

collaborator

VitalAire

INDUSTRY

collaborator

Laboratoire français de Fractionnement et de Biotechnologies

INDUSTRY

lead

University Hospital, Lille

OTHER

NCT05664035 - SPAD in Adult Patients | Biotech Hunter | Biotech Hunter